OCTLIGHT has been selected as one of the beneficiaries of the Horizon 2020 EU SME Instrument. Read the official press release here.
This is Phase 1 of the instrument, which grants the company €50,000 to be used for exploring and assessing the technical feasibility and commercial potential of a breakthrough innovation that a company wants to exploit and commercialize.
OCTLIGHT is one of seven Danish companies accepted in the first application round of 2017, joining the batch of 184 small- and medium-sized enterprises that was selected from a total of 2111 applicants.
Provided with about € 3 billion in funding over the period 2014-2020, the SME Instrument helps high-potential SMEs to develop groundbreaking innovative ideas for products, services or processes that are ready to face global market competition.
We look forward to work together with stakeholders towards improved diagnosis and treatment of eye diseases. Contact us to learn more.